A preliminary study of serum apoptosis-inhibiting molecule sFas and Bcl-2 in patients with Graves' disease
- VernacularTitle:Graves病患者血清中凋亡抑制因子sFas、Bcl-2的初步研究
- Author:
Fang YUAN
;
Yuezhong REN
;
Zuogui SONG
- Publication Type:Journal Article
- Keywords:
Graves' disease;
Apoptosis;
Fas(antigens,CD95);
Bcl-2(proto-oncogeneproteinsc-bcl-2)
- From:
Chinese Journal of Endocrinology and Metabolism
1985;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
sFas and Bcl-2 in serum were detected by ELISA in 30 patients with Graves′ disease (GD) before and after treatment 〔(0.76?0.24)ng/L vs (1.02?0.23)ng/L, (0.52?0.08)ng/L vs (0.87?0.15)ng/L〕 and in normal control subjects 〔(0.53?0.09)ng/L; (0.81?0.15)ng/L〕, the results indicated that sFas and Bcl-2 seem to be involved in the pathogenesis of GD.
